Biomm S.A. (BVMF:BIOM3)
Brazil
· Delayed Price · Currency is BRL 7.13
+0.13 (1.86%)
Jun 27, 2025, 5:06 PM GMT-3
Biomm Revenue
Biomm had revenue of 39.59M BRL in the quarter ending March 31, 2025, with 2.67% growth. This brings the company's revenue in the last twelve months to 143.94M, up 17.52% year-over-year. In the year 2024, Biomm had annual revenue of 142.91M with 20.91% growth.
Revenue (ttm)
143.94M
Revenue Growth
+17.52%
P/S Ratio
6.28
Revenue / Employee
1.11M
Employees
130
Market Cap
904.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 142.91M | 24.71M | 20.91% |
| Dec 31, 2023 | 118.19M | 13.24M | 12.62% |
| Dec 31, 2022 | 104.95M | -2.14M | -1.99% |
| Dec 31, 2021 | 107.09M | 48.42M | 82.54% |
| Dec 31, 2020 | 58.67M | 49.72M | 555.95% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 51.35B |
| Raia Drogasil | 39.81B |
| Hypera | 6.70B |
| Fleury | 7.80B |
| Odontoprev | 2.46B |
| Oncoclínicas do Brasil Serviços Médicos | 6.26B |
| Blau Farmacêutica | 1.77B |
| Empreendimentos Pague Menos | 13.13B |